These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 19429233)

  • 1. A stable human progesterone receptor expressing HeLa reporter cell line as a tool in chemical evaluation at the different cell-cycle phases.
    Mori T; Murata M; Yoshino T; Nakasono S; Saito F; Takeyama H; Matsunaga T
    Toxicol Lett; 2009 Apr; 186(2):123-9. PubMed ID: 19429233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of potential (anti)progestagenic endocrine disruptors using a recombinant human progesterone receptor binding and transactivation assay.
    Viswanath G; Halder S; Divya G; Majumder CB; Roy P
    Mol Cell Endocrinol; 2008 Nov; 295(1-2):1-9. PubMed ID: 18801410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human progesterone receptor A and B isoforms in CHO cells. I. Stable transfection of receptor and receptor-responsive reporter genes: transcription modulation by (anti)progestagens.
    Dijkema R; Schoonen WG; Teuwen R; van der Struik E; de Ries RJ; van der Kar BA; Olijve W
    J Steroid Biochem Mol Biol; 1998 Feb; 64(3-4):147-56. PubMed ID: 9605409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Time course of let-7a expression in the cell cycle of human cervical carcinoma HeLa cells].
    Zhou JY; Ma WL; Yu HL; Xiao WW; Zheng WL
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):442-5. PubMed ID: 19304520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reporter gene assay against lipophilic chemicals based on site-specific genomic recombination of a nuclear receptor gene, its response element, and a luciferase reporter gene within a stable HeLa cell line.
    Mori T; Saito F; Yoshino T; Takeyama H; Matsunaga T
    Biotechnol Bioeng; 2008 Apr; 99(6):1453-61. PubMed ID: 18023048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical appraisal of synchronization methods applied to achieve maximal enrichment of HeLa cells in specific cell cycle phases.
    Knehr M; Poppe M; Enulescu M; Eickelbaum W; Stoehr M; Schroeter D; Paweletz N
    Exp Cell Res; 1995 Apr; 217(2):546-53. PubMed ID: 7698256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Several synthetic chemicals inhibit progesterone receptor-mediated transactivation in yeast.
    Jin L; Tran DQ; Ide CF; McLachlan JA; Arnold SF
    Biochem Biophys Res Commun; 1997 Apr; 233(1):139-46. PubMed ID: 9144411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High concentrations of progesterone and mifepristone mutually reinforce cell cycle retardation and induction of apoptosis.
    Moe BG; Vereide AB; Orbo A; Sager G
    Anticancer Res; 2009 Apr; 29(4):1053-8. PubMed ID: 19414345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of progesterone receptor activity in yeast by synthetic chemicals.
    Tran DQ; Klotz DM; Ladlie BL; Ide CF; McLachlan JA; Arnold SF
    Biochem Biophys Res Commun; 1996 Dec; 229(2):518-23. PubMed ID: 8954930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a progesterone-sensitive cell line from human lung cancer.
    Nishizawa Y; Yamasaki M; Katayama H; Amakata Y; Fushiki S; Nishizawa Y
    Oncol Rep; 2007 Sep; 18(3):685-90. PubMed ID: 17671720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitive effect of 3-bromopyruvic acid on human breast cancer MCF-7 cells involves cell cycle arrest and apoptotic induction.
    Liu XH; Zheng XF; Wang YL
    Chin Med J (Engl); 2009 Jul; 122(14):1681-5. PubMed ID: 19719971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous [Ca2+]i oscillations in G1/S phase-synchronized cells.
    Russa AD; Maesawa C; Satoh Y
    J Electron Microsc (Tokyo); 2009 Oct; 58(5):321-9. PubMed ID: 19460967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levonorgestrel, medroxyprogesterone and progesterone cause a concentration-dependent reduction in endometrial cancer (Ishikawa) cell density, and high concentrations of progesterone and mifepristone act in synergy.
    Moe BT; Vereide AB; Orbo A; Jaeger R; Sager G
    Anticancer Res; 2009 Apr; 29(4):1047-52. PubMed ID: 19414344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the progesterone receptor genetic polymorphism +331G/A hPR influence the risk of venous thromboembolism among postmenopausal women using hormone therapy? The ESTHER Study.
    Bouaziz E; Canonico M; Verstuyft C; Carcaillon L; Martin F; Scarabin PY; Guiochon-Mantel A;
    Maturitas; 2009 Oct; 64(2):136-8. PubMed ID: 19782484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model.
    Mönckedieck V; Sannecke C; Husen B; Kumbartski M; Kimmig R; Tötsch M; Winterhager E; Grümmer R
    Mol Hum Reprod; 2009 Oct; 15(10):633-43. PubMed ID: 19671596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Met909 plays a key role in the activation of the progesterone receptor and also in the high potency of 13-ethyl progestins.
    Petit-Topin I; Turque N; Fagart J; Fay M; Ulmann A; Gainer E; Rafestin-Oblin ME
    Mol Pharmacol; 2009 Jun; 75(6):1317-24. PubMed ID: 19289570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dehydroepiandrosterone inhibits the proliferation and induces the death of HPV-positive and HPV-negative cervical cancer cells through an androgen- and estrogen-receptor independent mechanism.
    Girón RA; Montaño LF; Escobar ML; López-Marure R
    FEBS J; 2009 Oct; 276(19):5598-609. PubMed ID: 19702826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin enhances the chemosensitivity of GBC-SD cell line to doxorubicin through arresting the cell cycle to S phase rather than through the P53/Bax-depended apoptosis way in vitro.
    Songgang L; Jiyu L; Gongwei ; Yingbin L; Yiyu Q; Zhiwei Q
    Hepatogastroenterology; 2009; 56(94-95):1253-60. PubMed ID: 19950772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis and modulation of cell cycle control by bile acids in human leukemia T cells.
    Fimognari C; Lenzi M; Cantelli-Forti G; Hrelia P
    Ann N Y Acad Sci; 2009 Aug; 1171():264-9. PubMed ID: 19723064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.